| | | |   | | | | By Jayne Williamson-Lee Allen G. Breed/AP There was a staggering increase in requests for abortion pills through telemedicine in the months after the Dobbs decisions. Read More | | By Usha Lee McFarling Sylvia Jarrus for STAT The findings on pulse oximeters weren't published in widely read journals, weren't taught in medical schools, and never reached most doctors. Read More | | By Paul Hudson Adobe The innovative approaches biopharma companies adopted during the pandemic will revolutionize their work — and discoveries — going forward. Read More | | Sponsored Insight by ICON CLINICAL RESEARCH Maintaining the momentum in cell and gene therapy development In 2022, have been at least 11 CGTs pending approval in the US and six in the EU – how can drug developers maintain the momentum? Now is the time to lay the technical, regulatory, financial and logistical foundations that will embed CGT as a pivotal element of forward-looking health provision in years to come. Download this in-depth whitepaper to gain insights on the current market state and practicalities of clinical trials through long-term commercialization. | | By Brittany Trang SAMUEL CORUM/AFP via Getty Images Misinformation experts weigh in on how Elon Musk's Twitter takeover could impact fact-checking and content moderation on the site. Read More | |
No comments